The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Schwarze Katharina et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jul

Main|Search|PHGKB




Last Posted: Jul 31, 2019

---

• The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.
  Schwarze Katharina et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jul
• Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series.
  Taylor John et al. Genome medicine 2019 Jul 11(1) 46
• Identifying disparities in germline and somatic testing for ovarian cancer.
  Huang Marilyn et al. Gynecologic oncology 2019 153(2) 297-303
• Machine Learning for Health Services Researchers.
  Doupe Patrick et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2019 Jul 22(7) 808-815
• Valuing Health Surveillance as an Information System: Interdisciplinary Insights.
  Antoine-Moussiaux Nicolas et al. Frontiers in public health 2019 7138
• Testing for family influences on obesity: The role of genetic nurture.
  Cawley John et al. Health economics 2019 Jul 28(7) 937-952
• Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America.
  Justo Nahila et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2019 Jun 22(6) 739-749
• CyFiT telehealth: protocol for a randomised controlled trial of an online outpatient physiotherapy service for children with cystic fibrosis.
  Lang Ray Lei et al. BMC pulmonary medicine 2019 Jan 19(1) 21
• Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.
  Schofield Deborah et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 May
• Whole-Exome Sequencing and Chromosomal Microarray Analysis Feasible and Cost-Effective in an Underserved Population: Whole-exome sequencing and chromosomal microarray analysis are more expensive up front but are far more effective in making a genetic diagnosis and much less costly.
  et al. American journal of medical genetics. Part A 2018 176(5) 1044-1045

more